Timothy L. Ruchti,William Patrick Burgess,John Dumas, III,Ronald Lisiecki,Carol Dian Martin,Laura Santana,John Harrison Thornley,Joanne Marie Watt
申请号：
US16049676
公开号：
US20180333535A1
申请日:
2018.07.30
申请国别(地区):
US
年份:
2018
代理人:
摘要：
In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.
